Características auxológicas en pacientes pediátricos con déficit aislado permanente o transitorio de hormona del crecimiento. Respuesta al tratamiento y talla final

Carel, 2002, Adult height after long term treatment with recombinant growth hormone for idiopathic isolated growth hormone deficiency: Observational follow up study of the French population based registry, BMJ., 325, 70, 10.1136/bmj.325.7355.70 Deillon, 2015, Natural history of growth hormone deficiency in a pediatric cohort, Horm Res Paediat., 83, 252, 10.1159/000369392 Blethen, 1997, Adult height in growth hormone (GH)-deficient children treated with biosynthetic GH, J Clin Endocr Metab., 82, 418, 10.1210/jcem.82.2.3734 Reiter, 2006, Effect of growth hormone (GH) treatment on the near-final height of 1258 patients with idiopathic GH deficiency: Analysis of a large international database, J Clin Endocr Metab., 91, 2047, 10.1210/jc.2005-2284 Bidlingmaier, 2010, Measurement of human growth hormone by immunoassays: Current status, unsolved problems and clinical consequences, Growth Horm IGF Res., 20, 19, 10.1016/j.ghir.2009.09.005 Grimberg, 2016, Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: Growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency, Horm Res Paediat., 86, 361, 10.1159/000452150 Wagner, 2014, Clinical evidence-based cutoff limits for GH stimulation tests in children with a backup of results with reference to mass spectrometry, Eur J Endocrinol., 171, 389, 10.1530/EJE-14-0165 Biller, 2002, Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency, J Clin Endocr Metab., 87, 2067, 10.1210/jcem.87.5.8509 Secco, 2009, Reassessment of the growth hormone status in young adults with childhood-onset growth hormone deficiency: Reappraisal of insulin tolerance testing, J Clin Endocr Metab., 94, 4195, 10.1210/jc.2009-0602 Maghnie, 2005, Diagnosis of GH deficiency in the transition period: Accuracy of insulin tolerance test and insulin-like growth factor-I measurement, Eur J Endocrinol., 152, 589, 10.1530/eje.1.01873 Dirección General de Farmacia y Productos Sanitarios, Comité asesor para la hormona del crecimiento, Ministerio de Sanidad y Consumo. Criterios para la utilización racional de la hormona del crecimiento en adultos. Aprobado el 20 de Sep de 2004 [consultado 22 May 2018]. Disponible en: http://www.mscbs.gob.es/profesionales/farmacia/pdf/criteriosHCAdultos291009.pdf. Sobradillo, 2004, Curvas y tablas de crecimiento (estudios longitudinal y transversal). Instituto de Investigación sobre Crecimiento y Desarrollo, Fundación Faustino Orbegozo Eizaguirre. Bayley, 1952, Tables for predicting adult height from skeletal age: Revised for use with the Greulich-Pyle hand standards, J Pediatr, 40, 423, 10.1016/S0022-3476(52)80205-7 Cohen, 2008, Consensus statement on the diagnosis and treatment of children with idiopathic short stature: A summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop, J Clin Endocr Metab., 93, 4210, 10.1210/jc.2008-0509 Dirección General de Farmacia y Productos Sanitarios, Comité asesor para la hormona del crecimiento, Ministerio de Sanidad y Consumo. Criterios para la utilización racional de la hormona del crecimiento en niños. Aprobado el 30 de May de 2008 [consultado 18 May 2018]. Disponible en: http://www.mscbs.gob.es/profesionales/farmacia/pdf/criteriosHCninos020908.pdf. Cacciari, 1997, Final height of patients treated for isolated GH deficiency: Examination of 83 patients, Eur J Endocrinol., 137, 53, 10.1530/eje.0.1370053 Cutfield, 1999, Final height in idiopathic growth hormone deficiency: The KIGS experience. KIGS International Board, Acta Paediatr Suppl., 88, 72, 10.1111/j.1651-2227.1999.tb14356.x Thomas, 2001, Final height in children with idiopathic growth hormone deficiency treated with recombinant human growth hormone: The Belgian experience, Horm Res., 55, 88 Cardoso, 2014, Comparison between the growth response to growth hormone (GH) therapy in children with partial GH insensitivity or mild GH deficiency, Arq Bras Endocrinol., 58, 23, 10.1590/0004-2730000002793 Salah, 2013, Egyptian growth hormone deficient patients: Demographic, auxological characterization and response to growth hormone therapy, J Pediatr Endocr Met., 26, 257 Smyczyńska, 2014, Incidence and predictors of persistent growth hormone deficiency (GHD) in patients with isolated, childhood-onset GHD, Endokrynol Pol., 65, 334, 10.5603/EP.2014.0046 Westphal, 2008, Final height in Swedish children with idiopathic growth hormone deficiency enrolled in KIGS treated optimally with growth hormone, Acta Paediatr., 97, 1698, 10.1111/j.1651-2227.2008.01053.x Tauber, 1997, Growth hormone (GH) retesting and auxological data in 131 GH-deficient patients after completion of treatment, J Clin Endocr Metab., 82, 352, 10.1210/jcem.82.2.3726 Rodríguez Arnao, 2014, The DATAC study: A new growth database description of the epidemiology, diagnosis and therapeutic attitude in a group of Spanish children with short stature, J Pediatr Endocr Met., 27, 1201 Stochholm, 2006, Incidence of GH deficiency–a nationwide study, Eur J Endocrinol., 155, 61, 10.1530/eje.1.02191 Deal, 2009, Abnormal MRI in GH-deficient patients: Association with clinical presentation, hormonal status and 1st year GH response, Horm Res., 72, 42 Bell, 2010, Long-term safety of recombinant human growth hormone in children, J Clin Endocr Metab., 95, 167, 10.1210/jc.2009-0178 Sävendahl, 2012, Long-term mortality and causes of death in isolated GHD, ISS, and SGA patients treated with recombinant growth hormone during childhood in Belgium, The Netherlands, and Sweden: Preliminary report of 3 countries participating in the EU SAGhE study, J Clin Endocr Metab., 97, E213, 10.1210/jc.2011-2882